ArticleArchives of rehabilitation research and clinical translation2025
Associations of Sarcopenia With Medical Events and Inpatient Rehabilitation Outcomes in ACC/AHA Stage A, B, and C Heart Failure Individuals With Disabilities.
Article in Archives of rehabilitation research and clinical translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the associations of sarcopenia with medical events and inpatient rehabilitation outcomes in American College of Cardiology (ACC)/American Heart Association (AHA) stage A, B, and C patients with heart failure (HF) and disabilities. Design: Retrospective cohort study. Setting: Inpatient rehabilitation ward. Participants: ACC/AHA stage A, B, and C patients with HF (N=293) with or without sarcopenia who had disabilities because of neurologic disorders, musculoskeletal disorders, or hospital-associated deconditioning. Interventions: None. Main Outcome Measures: The primary outcomes were medical events such as death and illness requiring interhospital transport for specialized medical care. The secondary outcomes were inpatient rehabilitation outcomes, including improvement efficiency of the FIM (gain in FIM score divided by length of stay) for motor function (FIM-M) and cognitive function (FIM-C). Results: The adjusted hazard ratio indicating risk for medical events in the ACC/AHA stage A, B, and C HF with sarcopenia group relative to those without sarcopenia group was 2.93 (95% CI, 1.12-7.67). The β coefficients of the ACC/AHA stage A, B, and C HF with sarcopenia group relative to those without sarcopenia group for the improvement efficiencies of FIM-M and FIM-C were 0.11 (lower confidence limit: -0.33, upper confidence limit: 0.56) and -0.28 (lower confidence limit: -1.51, upper confidence limit: 0.997), respectively. Conclusions: This study showed that sarcopenia was significantly associated with medical events but not with inpatient rehabilitation outcomes in ACC/AHA stage A, B, and C HF patients with disabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.